Johnson & Johnson rolls out next-gen intraocular lens

Johnson & Johnson (NYSE: JNJ)+ announced today that it expanded the rollout of its latest Tecnis Odyssey presbyopia-correcting intraocular lenses (PC-IOLs).

The new full visual range IOL offers a continuous, full range of vision, enabling sight from far, near and in between. It minimzes the need for glasses for those with presbyiopia, according to a news relesae.

J&J built the IOL on its existing Tecnis platform. The company said it provides two-times better contrast in low lighting compared to the Alcon PanOptix IOL. It also touts the ability for patients to read 14% smaller print on average compared to PanOptix users. Additionally, 93% of users reported zero or mild halos, glare or starbursts one month after surgery.

The company said it built Tecnis Odyssey with proprietary technology that results in superior image quality. It delivers sharp vision even in challenging lighting conditions, plus fewer visual disturbances. Johnson & Johnson says 94% of patients reported satisfaction with their overall vision without glasses.

Sign up for Blog Updates